15 Subject Panel
3 samples per subject
Sample 1: ≤ 2 days prior to the first vaccination
Sample 2: ≤ 2 days prior to their second vaccination
Sample 3: 13-15 days post their second vaccination
• Some subjects with previous COVID infections
• Serum only
• 1mL samples
• Methodology: DiaSorin LIAISON SARS-CoV-2 S1/S2 IgG
View specimen log here
Disclaimer: Individual donor units used in the preparation of this product have been tested and found negative by tests for antibodies to HIV 1 / 2, HCV and non-reactive for HBsAg. Pooled samples were found non-reactive for HIV 1 RNA, HBV DNA and HCV RNA by Nucleic Acid Test. All testing performed with kits approved by the FDA. Each donor has been tested and found negative for syphilis according to FDA guidelines.